Get the Stockscreener App
3.21
5.59%
0.17
Abvc Biopharma Inc stock is traded at $3.21, with a volume of 143.34K.
It is up +5.59% in the last 24 hours and up +6.64% over the past month.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
See More
Previous Close:
$3.04
Open:
$3.07
24h Volume:
143.34K
Relative Volume:
0.36
Market Cap:
$75.57M
Revenue:
$152.40K
Net Income/Loss:
$-10.52M
P/E Ratio:
-1.2876
EPS:
-2.4931
Net Cash Flow:
$-4.26M
1W Performance:
-2.73%
1M Performance:
+6.64%
6M Performance:
+358.83%
1Y Performance:
+352.11%
1-Day Range:
$3.07
$3.3545
1-Week Range:
$2.85
$3.3545
52-Week Range:
$0.40
$5.48
Abvc Biopharma Inc Stock (ABVC) Company Profile
Name
Abvc Biopharma Inc
Sector
Industry
Phone
510-668-0881
Address
44370 OLD WARM SPRINGS BLVD., FREMONT
Compare ABVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
3.21 | 73.69M | 152.40K | -10.52M | -4.26M | -2.4931 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Abvc Biopharma Inc Stock (ABVC) Latest News
Using data tools to time your ABVC BioPharma Inc. exitMarket Sentiment Review & Free Safe Entry Trade Signal Reports - Newser
How to interpret RSI for ABVC BioPharma Inc. stockNew Guidance & Community Trade Idea Sharing - Newser
Statistical indicators supporting ABVC BioPharma Inc.’s strengthWeekly Investment Report & Fast Moving Trade Plans - Newser
Visualizing ABVC BioPharma Inc. stock with heatmapsRate Cut & Expert Curated Trade Setup Alerts - Newser
Will ABVC BioPharma Inc. stock recover after recent dropCEO Change & Short-Term Trading Opportunity Alerts - Newser
Historical volatility pattern of ABVC BioPharma Inc. visualized2025 Investor Takeaways & Daily Technical Stock Forecast Reports - Newser
Published on: 2025-08-19 13:50:50 - Newser
Using R and stats models for ABVC BioPharma Inc. forecastingProfit Target & AI Based Trade Execution Alerts - Newser
What moving averages say about ABVC BioPharma Inc.Earnings Trend Report & Daily Growth Stock Tips - Newser
Published on: 2025-08-19 01:06:27 - Newser
How ABVC BioPharma Inc. stock performs during market volatilityPortfolio Performance Summary & Fast Entry High Yield Tips - Newser
ABVC BioPharma Inc.’s Beta Climbs After Market VolatilityJuly 2025 Institutional & Expert Curated Trade Ideas - newsimpact.co.kr
Using RSI to spot recovery in ABVC BioPharma Inc.Market Weekly Review & Daily Volume Surge Signals - Newser
Why ABVC BioPharma Inc. stock attracts strong analyst attentionJuly 2025 Review & Fast Gaining Stock Reports - Newser
How to integrate ABVC BioPharma Inc. into portfolio analysis toolsWeekly Trend Recap & Accurate Technical Buy Alerts - Newser
Regression analysis insights on ABVC BioPharma Inc. performanceMarket Performance Summary & Community Consensus Picks - Newser
What institutional flow reveals about ABVC BioPharma Inc.July 2025 Intraday Action & Community Consensus Trade Alerts - Newser
Intraday pattern recognizer results for ABVC BioPharma Inc.Weekly Profit Report & AI Forecast Swing Trade Picks - Newser
What indicators show strength in ABVC BioPharma Inc.July 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser
XTX Topco Ltd Purchases 26,034 Shares of ABVC BioPharma, Inc. (NASDAQ:ABVC) - Defense World
Volatility clustering patterns for ABVC BioPharma Inc.Long Setup & Reliable Breakout Stock Forecasts - Newser
Analyzing ABVC BioPharma Inc. with multi timeframe chartsExit Point & Expert Approved Momentum Ideas - Newser
Using economic indicators to assess ABVC BioPharma Inc. potentialMarket Activity Summary & Technical Entry and Exit Alerts - Newser
Top 5 Small-cap Pharma Stocks to Watch in 2025: ABVC BioPharma Leads the Pack - AInvest
Abvc BioPharma Q2 Results: Assets Double, Shareholders' Equity Rises, No Revenue Reported. - AInvest
Real time scanner hits for ABVC BioPharma Inc. explainedForecast Cut & Real-Time Market Trend Scan - Newser
ABVC BioPharma Q1 2025 Earnings: Loss Narrows to $0.19 per Share, Net Loss at $3.10m. - AInvest
ABVC BioPharma First Half 2025 Earnings: US$0.19 loss per share (vs US$0.36 loss in 1H 2024) - Yahoo Finance
What makes ABVC BioPharma Inc. stock price move sharply2025 Macro Impact & Verified Momentum Stock Ideas - Newser
Abvc BioPharma Doubles Assets in Q2 - AOL.com
ABVC BioPharma Inc. Attempts Reversal From Key SupportInsider Buying & Reliable Price Breakout Signals - beatles.ru
Top 5 Small-cap Pharma Stocks of 2025 - Nasdaq
Abvc BioPharma Q2 2025 Financial Results: Total Assets Double to $16.2 Million - AInvest
ABVC BioPharma Reports 103% YoY Asset Growth and Secures $350K in Licensing Revenue in Q2 2025 - AInvest
ABVC BioPharma, Inc. Reports 103% Year-Over-Year Asset Growth and Secures $350K in Post-Quarter Licensing Revenue in Q2 2025 - Yahoo Finance
ABVC BioPharma 2024 Q4 Earnings Strong Turnaround as Net Income Surges 118.4% - AInvest
Is now a turning point for ABVC BioPharma Inc.July 2025 Macro Moves & Advanced Technical Signal Analysis - Newser
News impact scoring models applied to ABVC BioPharma Inc.Exit Point & Fast Exit and Entry Trade Guides - Newser
Smart tools for monitoring ABVC BioPharma Inc.’s price actionJuly 2025 Intraday Action & Community Consensus Trade Alerts - Newser
Is ABVC BioPharma Inc. stock a growth or value playMarket Sentiment Report & Weekly Top Performers Watchlists - Newser
Live Chart Scan Detects Wedge Pattern in ABVC BioPharma Inc.July 2025 Price Swings & Daily Entry Point Alerts - beatles.ru
Abvc Biopharma Inc Stock (ABVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):